<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="69135">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02205801</url>
  </required_header>
  <id_info>
    <org_study_id>IRB14-0374</org_study_id>
    <nct_id>NCT02205801</nct_id>
  </id_info>
  <brief_title>Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and Parathyroidectomy</brief_title>
  <official_title>A Randomized Control Trial Comparing Bilateral Superficial Cervical Plexus Block and Local Wound Infiltration in Thyroidectomy and Parathyroidectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to study the effect of local anesthetic when used in conjunction with general
      anesthesia during thyroidectomy or parathyroidectomy. We hypothesize there is equivalent
      pain control between bilateral superficial cervical plexus block and local wound
      infiltration when used in conjunction with a general anesthetic.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>July 2014</start_date>
  <primary_completion_date type="Anticipated">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative opioid utilization</measure>
    <time_frame>Intraoperative</time_frame>
    <description>The amount of Fentanyl administered during the procedure will be recorded.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post operative pain</measure>
    <time_frame>perioperative, post operative day one, follow up appointment 1-2 weeks postoperatively</time_frame>
    <description>Pain scores will either be verbally reported to nursing and recorded or reported on a questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post operative nausea and vomiting</measure>
    <time_frame>perioperative, post operative day one, follow up appointment 1-2 weeks postoperatively</time_frame>
    <description>Nausea scores and number of episodes of emesis will either be verbally reported to nursing and recorded or reported on a questionnaire.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total pain medication utilization</measure>
    <time_frame>At follow up appointment 1-2 weeks postoperatively</time_frame>
    <description>The patient will report on a questionnaire the amount of pain medication utilized.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Thyroid Neoplasms</condition>
  <condition>Goiter, Nodular</condition>
  <condition>Thyroid Nodule</condition>
  <condition>Graves' Disease</condition>
  <condition>Hyperparathyroidism</condition>
  <arm_group>
    <arm_group_label>superficial cervical block, active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.25% Marcaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local wound infiltration, placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After induction of general anesthesia the surgeon will perform local wound infiltration using 0.9% Saline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>local wound infiltration, active</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After induction of general anesthesia the surgeon will perform a local wound infiltration using 0.25% Marcaine.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>superficial cervical block, placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After induction of general anesthesia the surgeon will perform a bilateral superficial cervical plexus block using 0.9% saline.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Superficial Cervical Plexus Block</intervention_name>
    <description>0.25% Marcaine is injected lateral to the sternocleidomastoid bilaterally (10mL on each side) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy.</description>
    <arm_group_label>superficial cervical block, active</arm_group_label>
    <arm_group_label>superficial cervical block, placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local Wound Infiltration</intervention_name>
    <description>0.25% Marcaine is injected at the site of incision (20mL) after induction of anesthesia and prior to incision and scheduled thyroidectomy or parathyroidectomy.</description>
    <arm_group_label>local wound infiltration, placebo</arm_group_label>
    <arm_group_label>local wound infiltration, active</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% saline</intervention_name>
    <arm_group_label>local wound infiltration, placebo</arm_group_label>
    <arm_group_label>superficial cervical block, placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Marcaine</intervention_name>
    <arm_group_label>superficial cervical block, active</arm_group_label>
    <arm_group_label>local wound infiltration, active</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient â‰¥ 18 years old

          -  Surgical indication for parathyroidectomy or thyroidectomy

        Exclusion Criteria:

          -  Patients &lt; 18 years old

          -  Patient with history of chronic opioid use

          -  Patient with chronic pain syndromes

          -  Patient with allergy to marcaine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymon Grogan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 29, 2016</lastchanged_date>
  <firstreceived_date>July 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Thyroid Diseases</mesh_term>
    <mesh_term>Hyperparathyroidism</mesh_term>
    <mesh_term>Graves Disease</mesh_term>
    <mesh_term>Thyroid Nodule</mesh_term>
    <mesh_term>Thyroid Neoplasms</mesh_term>
    <mesh_term>Goiter, Nodular</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
